Archives: Search / 2017 / 2016 / 2015 / 2014 / 2013 / 2012 / 2011 / 2010 / 2009 / 2008

200720062004

2011 Archives

Dec 12, 2011

Philadelphia, PA – December 12, 2011 – Lannett Company, Inc. (NYSE AMEX: LCI) today announced it has received approval from the U.S. Food and Drug Administration (FDA) of its...

More
Dec 7, 2011

Philadelphia, PA – December 7, 2011 – Lannett Company, Inc. (NYSE AMEX: LCI) today announced that the company will present at the Oppenheimer 22nd Annual Healthcare Conference on...

More
Nov 10, 2011

Philadelphia, PA – November 10, 2011 – Lannett Company, Inc. (NYSE AMEX: LCI) today announced that the company will present at the Lazard Capital Markets 8th Annual Healthcare...

More
Nov 3, 2011

Philadelphia, PA – November 3, 2011 – Lannett Company, Inc. (NYSE AMEX: LCI) today reported increased sales and income for the fiscal 2012 first quarter ended September 30, 2011. Net...

More
Oct 27, 2011

Philadelphia, PA – October 27, 2011 – Lannett Company, Inc. (NYSE Amex: LCI), a manufacturer of generic pharmaceuticals, today announced that the company will release its fiscal 2012...

More
Oct 24, 2011

Philadelphia, PA – October 24, 2011 – Lannett Company, Inc. (NYSE AMEX: LCI) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) of its...

More
Oct 14, 2011

Philadelphia, PA – October 14, 2011 – Lannett Company, Inc. (NYSE AMEX: LCI) today announced that it has commenced shipping three products - Diethylpropion Tablets 25mg, Phentermine...

More
Sep 27, 2011

Philadelphia, PA – September 27, 2011 – Lannett Company, Inc. (NYSE AMEX: LCI) today announced it has received approval from the U.S. Food and Drug Administration (FDA) for its...

More
Sep 13, 2011

Philadelphia, PA – September13, 2011 – Lannett Company, Inc. (NYSE AMEX: LCI) today announced that the company will present at the UBS Global Life Sciences Conference on Monday,...

More
Sep 12, 2011

Philadelphia, PA – September 12, 2011 – Lannett Company, Inc. (AMEX:LCI), a manufacturer of generic pharmaceuticals, today announced that Arthur Bedrosian, the company’s president...

More
Sep 7, 2011

Philadelphia, PA – September 7, 2011 – Lannett Company, Inc. (NYSE AMEX: LCI) today reported financial results for the fiscal 2011 fourth quarter and full year ended June 30, 2011. For...

More
Sep 1, 2011

Philadelphia, PA – September 1, 2011 – Lannett Company, Inc. (NYSE Amex: LCI), a manufacturer of generic pharmaceuticals, today announced that the company will release its fiscal 2011...

More
Aug 16, 2011

Philadelphia, PA – August 16, 2011 – Lannett Company, Inc. (NYSE AMEX: LCI) today announced the appointment of Jeffrey Farber as Vice Chairman of the Board. Farber, 50, has served as a...

More
Aug 11, 2011

Philadelphia, PA – August 11, 2011 – Lannett Company, Inc. (NYSE AMEX: LCI) today announced that it has commenced shipping of its Morphine Sulfate Oral Solution product. The company...

More
Aug 8, 2011

Philadelphia, PA – August 8, 2011 – Lannett Company, Inc. (NYSE AMEX: LCI) today announced the appointment of Martin P. Galvan as chief financial officer, succeeding Keith Ruck, who...

More
Aug 2, 2011

Philadelphia, PA – August 2, 2011 – Lannett Company, Inc. (NYSE AMEX: LCI) today announced that Keith Ruck has resigned as chief financial officer to pursue other interests. The...

More
Jul 29, 2011

Philadelphia, PA – July 29, 2011 – Lannett Company, Inc. (NYSE AMEX: LCI) today announced the U.S. Food and Drug Administration (FDA) approved its Abbreviated New Drug Application...

More
Jul 20, 2011

Philadelphia, PA – July 20, 2011 – Lannett Company, Inc. (NYSE AMEX: LCI) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) for its...

More
Jul 18, 2011

Philadelphia, PA – July 18, 2011 – Lannett Company, Inc. (NYSE AMEX: LCI) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) for its...

More
Jul 5, 2011

Philadelphia, PA – July 5, 2011 – Lannett Company, Inc. (NYSE AMEX: LCI) today announced the promotion of Robert Ehlinger to vice president of logistics and chief information officer....

More
Jun 24, 2011

Philadelphia, PA – June 24, 2011 – Lannett Company, Inc. (NYSE AMEX: LCI) today announced that the U.S. Food and Drug Administration (FDA) has approved the company’s 505(b)(2) New...

More
Jun 6, 2011

Philadelphia, PA – June 6, 2011 – Lannett Company, Inc. (NYSE AMEX: LCI) announced today that the U.S. Food and Drug Administration (FDA) has issued a revised Prescription Drug User...

More
Jun 1, 2011
Ronald A. West Appointed Chairman; William Farber Named Chairman Emeritus

Philadelphia, PA – June 1, 2011 – The Board of Directors of Lannett Company, Inc. (NYSE AMEX: LCI) today announced that effective July 1, 2011 Ronald A. West will become Chairman of...

More
May 18, 2011

Philadelphia, PA – May 18, 2011 – Lannett Company, Inc. (NYSE AMEX: LCI) today announced Arthur Bedrosian, president and chief executive officer, purchased 5,000 shares of the company’s

More
 

print email rss
Lannett Investor Relations
Lannett Company Products